New meningitis vaccine trial aims to protect 240 volunteers
NCT ID NCT06834100
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new vaccine called GNG-DE to see how well it protects against meningococcal infections (a cause of meningitis). About 240 people aged 3 to 55 will receive either the new vaccine or a reference vaccine. Researchers will measure immune responses and check for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Federal Budgetary Scientific Institution "Central Research Institute of Epidemiology" of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
RECRUITINGMoscow, Russia
-
Federal State Budgetary Educational Institution of Higher Education "Kirov State Medical University" of the Ministry of Health of the Russian Federation
COMPLETEDKirov, Russia
-
Federal State Budgetary Educational Institution of Higher Education "National Research Mordovian State University named after N.P. Ogarev"
RECRUITINGSaransk, Russia
-
Federal State Budgetary Educational Institution of Higher Education "Perm State Medical University named after Academician E.A. Wagner" of the Ministry of Health of the Russian Federation
COMPLETEDPerm, Russia
-
Federal State Budgetary Educational Institution of Higher Education "Smolensk State Medical University" of the Ministry of Health of the Russian Federation
RECRUITINGSmolensk, Russia
-
Federal State Budgetary Institution "A. A. Smorodintsev Research Institute of Influenza" of the Ministry of Health of the Russian Federation
COMPLETEDSaint Petersburg, Russia
-
Federal State Budgetary Institution "Children's Scientific and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency"
COMPLETEDSaint Petersburg, Russia
-
Federal State Budgetary Scientific Institution "I.I. Mechnikov Research Institute of Vaccines and Serums"
COMPLETEDMoscow, Russia
-
Federal State Budgetary Scientific Institution "Russian Scientific Center of Surgery named after Academician B.V. Petrovsky"
RECRUITINGMoscow, Russia
-
Limited Liability Company "DNA Research Center"
RECRUITINGSaratov, Russia
-
Limited Liability Company "DNA Research Center"
COMPLETEDSaratov, Russia
-
Limited Liability Company "Energy of Health"
RECRUITINGSaint Petersburg, Russia
-
Limited Liability Company "PiterClinic"
RECRUITINGSaint Petersburg, Russia
-
Saint Petersburg State Budgetary Healthcare Institution "Children's City Polyclinic No. 44"
RECRUITINGSaint Petersburg, Russia
-
State Budgetary Healthcare Institution of Perm Krai "City Children's Clinical Polyclinic No. 5"
RECRUITINGPerm, Russia
-
State Budgetary Healthcare Institution of the Sverdlovsk Region "Central City Hospital No. 7, Yekaterinburg"
COMPLETEDYekaterinburg, Russia
-
State Budgetary Institution of Healthcare of the City of Moscow "Morozovskaya Children's City Clinical Hospital of the Moscow City Healthcare Department"
RECRUITINGMoscow, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
- Experimental malaria vaccine aims to block parasite growth
- Rare disease drug shows promise in reducing infections
- New rapid test for infection and inflammation put to the test
- Fast new swab test could speed up vaginitis diagnosis
- Scientists crack the code of antibiotic-friendly superbug